| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | DENND6 | 1.59e-05 | 2 | 75 | 2 | IPR024224 | |
| Domain | Avl9 | 9.50e-05 | 4 | 75 | 2 | PF09794 | |
| Domain | ABL9/DENND6_dom | 9.50e-05 | 4 | 75 | 2 | IPR018307 | |
| Domain | YTH_domain | 1.58e-04 | 5 | 75 | 2 | IPR007275 | |
| Domain | YTH | 1.58e-04 | 5 | 75 | 2 | PS50882 | |
| Domain | YTH | 1.58e-04 | 5 | 75 | 2 | PF04146 | |
| Domain | HEAT_REPEAT | 1.80e-04 | 70 | 75 | 4 | PS50077 | |
| Domain | HEAT | 9.45e-04 | 48 | 75 | 3 | PF02985 | |
| Domain | HEAT | 1.64e-03 | 58 | 75 | 3 | IPR000357 | |
| Domain | - | 1.99e-03 | 222 | 75 | 5 | 1.25.10.10 | |
| Domain | TSP_1 | 2.08e-03 | 63 | 75 | 3 | PF00090 | |
| Domain | TSP1 | 2.27e-03 | 65 | 75 | 3 | SM00209 | |
| Domain | TSP1_rpt | 2.27e-03 | 65 | 75 | 3 | IPR000884 | |
| Domain | TSP1 | 2.27e-03 | 65 | 75 | 3 | PS50092 | |
| Domain | ARM-type_fold | 2.41e-03 | 339 | 75 | 6 | IPR016024 | |
| Domain | ARM-like | 4.61e-03 | 270 | 75 | 5 | IPR011989 | |
| Domain | ZINC_PROTEASE | 7.20e-03 | 98 | 75 | 3 | PS00142 | |
| Pubmed | DOCK5 ARHGEF1 XRN1 LPGAT1 ERGIC2 HPS5 YTHDF2 CEMIP2 ESF1 FARP2 | 2.19e-06 | 650 | 79 | 10 | 38777146 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 32173454 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 15715521 | ||
| Pubmed | YTHDF2/3 Are Required for Somatic Reprogramming through Different RNA Deadenylation Pathways. | 5.09e-06 | 2 | 79 | 2 | 32905781 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 19246519 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 31081967 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 20018982 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 23119079 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 20374961 | ||
| Pubmed | Dedicator of Cytokinesis 5 Regulates Keratinocyte Function and Promotes Diabetic Wound Healing. | 5.09e-06 | 2 | 79 | 2 | 33627322 | |
| Pubmed | 8.69e-06 | 210 | 79 | 6 | 16565220 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 30292429 | ||
| Pubmed | YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA. | 1.53e-05 | 3 | 79 | 2 | 28106072 | |
| Pubmed | YTHDF2 suppresses the plasmablast genetic program and promotes germinal center formation. | 1.53e-05 | 3 | 79 | 2 | 35508130 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 12368078 | ||
| Pubmed | Insulin signaling in LepR cells modulates fat and glucose homeostasis independent of leptin. | 1.53e-05 | 3 | 79 | 2 | 30376348 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 25125486 | ||
| Pubmed | A Unified Model for the Function of YTHDF Proteins in Regulating m6A-Modified mRNA. | 1.53e-05 | 3 | 79 | 2 | 32492408 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 19188430 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 30418175 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 22728933 | ||
| Pubmed | The beta secretase BACE1 regulates the expression of insulin receptor in the liver. | 1.53e-05 | 3 | 79 | 2 | 29610518 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 31292544 | ||
| Pubmed | Insulin and Leptin Signaling Interact in the Mouse Kiss1 Neuron during the Peripubertal Period. | 1.53e-05 | 3 | 79 | 2 | 25946091 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 38636894 | ||
| Pubmed | Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. | 1.53e-05 | 3 | 79 | 2 | 22575960 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 34497675 | ||
| Pubmed | m6A modification controls the innate immune response to infection by targeting type I interferons. | 1.53e-05 | 3 | 79 | 2 | 30559377 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 22278432 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 34773742 | ||
| Pubmed | m6A-binding YTHDF proteins promote stress granule formation. | 1.53e-05 | 3 | 79 | 2 | 32451507 | |
| Pubmed | Inter-organ insulin-leptin signal crosstalk from the liver enhances survival during food shortages. | 1.53e-05 | 3 | 79 | 2 | 37116488 | |
| Pubmed | N(6)-methyladenosine of HIV-1 RNA regulates viral infection and HIV-1 Gag protein expression. | 1.53e-05 | 3 | 79 | 2 | 27371828 | |
| Pubmed | The Maternal Microbiome Programs the m6A Epitranscriptome of the Mouse Fetal Brain and Intestine. | 2.50e-05 | 25 | 79 | 3 | 35874829 | |
| Pubmed | NPEPPS ARHGEF1 LPGAT1 MIGA1 ERGIC2 WARS2 CDKAL1 NDUFS8 FARP2 | 2.58e-05 | 686 | 79 | 9 | 28380382 | |
| Pubmed | Acute effects of zinc and insulin on arcuate anorexigenic proopiomelanocortin neurons. | 3.05e-05 | 4 | 79 | 2 | 30521677 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 27213816 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 22595670 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 34914893 | ||
| Pubmed | A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. | 3.05e-05 | 4 | 79 | 2 | 32005828 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 17369526 | ||
| Pubmed | Hemicentin 1 influences podocyte dynamic changes in glomerular diseases. | 3.05e-05 | 4 | 79 | 2 | 29488390 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 25205222 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 21330364 | ||
| Pubmed | DOCK5 regulates energy balance and hepatic insulin sensitivity by targeting mTORC1 signaling. | 3.05e-05 | 4 | 79 | 2 | 31885214 | |
| Pubmed | Astrocytic Insulin Signaling Couples Brain Glucose Uptake with Nutrient Availability. | 3.05e-05 | 4 | 79 | 2 | 27518562 | |
| Pubmed | Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders. | 3.05e-05 | 4 | 79 | 2 | 23354051 | |
| Pubmed | Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells. | 3.05e-05 | 4 | 79 | 2 | 21346174 | |
| Pubmed | N6-methyladenosine-dependent regulation of messenger RNA stability. | 3.05e-05 | 4 | 79 | 2 | 24284625 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 26340929 | ||
| Pubmed | 4.32e-05 | 733 | 79 | 9 | 34672954 | ||
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 23348573 | ||
| Pubmed | Context-dependent functional compensation between Ythdf m6A reader proteins. | 5.07e-05 | 5 | 79 | 2 | 32943573 | |
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 32183843 | ||
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 29212950 | ||
| Pubmed | SMPDL3b modulates insulin receptor signaling in diabetic kidney disease. | 5.07e-05 | 5 | 79 | 2 | 31217420 | |
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 24206663 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PDIA4 NCAPG COPG1 ARHGEF1 LPGAT1 UTP20 HEATR1 TUBGCP2 CDKAL1 NDUFS8 | 5.39e-05 | 942 | 79 | 10 | 31073040 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | BAZ2B BCLAF1 HEATR1 SRSF9 YTHDF2 TOP2A YTHDF3 ESF1 NDUFS8 KNL1 | 5.99e-05 | 954 | 79 | 10 | 36373674 |
| Pubmed | Gli1+ Periodontium Stem Cells Are Regulated by Osteocytes and Occlusal Force. | 7.60e-05 | 6 | 79 | 2 | 32652075 | |
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 12595588 | ||
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 27848995 | ||
| Pubmed | Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance. | 7.60e-05 | 6 | 79 | 2 | 19122674 | |
| Pubmed | Central insulin action regulates peripheral glucose and fat metabolism in mice. | 7.60e-05 | 6 | 79 | 2 | 18451994 | |
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 25754093 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PDIA4 NCAPG COPG1 BCLAF1 NPEPPS UTP20 HEATR1 SRSF9 TOP2A ESF1 NDUFS8 MYBPC1 | 8.63e-05 | 1425 | 79 | 12 | 30948266 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 9.00e-05 | 807 | 79 | 9 | 22681889 | |
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 22969086 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 1.12e-04 | 647 | 79 | 8 | 26618866 | |
| Pubmed | BCLAF1 NPEPPS WWP1 INSR XRN1 SRSF9 TOP2A YTHDF3 HEXIM2 ESF1 DNAH1 | 1.17e-04 | 1247 | 79 | 11 | 27684187 | |
| Pubmed | Glucagon regulates hepatic kisspeptin to impair insulin secretion. | 1.41e-04 | 8 | 79 | 2 | 24703698 | |
| Pubmed | PDIA4 SOST RIPOR2 RNMT ARHGEF1 WWP1 IRAK4 HEATR1 YTHDF3 ESF1 | 1.70e-04 | 1084 | 79 | 10 | 11544199 | |
| Pubmed | 1.82e-04 | 9 | 79 | 2 | 9819414 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 2.01e-04 | 370 | 79 | 6 | 22922362 | |
| Pubmed | Condensins I and II are essential for construction of bivalent chromosomes in mouse oocytes. | 2.27e-04 | 10 | 79 | 2 | 21795393 | |
| Pubmed | UBE2O negatively regulates TRAF6-mediated NF-κB activation by inhibiting TRAF6 polyubiquitination. | 2.27e-04 | 10 | 79 | 2 | 23381138 | |
| Pubmed | 2.27e-04 | 10 | 79 | 2 | 18828733 | ||
| Pubmed | 2.27e-04 | 10 | 79 | 2 | 22969705 | ||
| Pubmed | 2.27e-04 | 10 | 79 | 2 | 20503258 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NCAPG COPG1 NPEPPS ARHGEF1 XRN1 UTP20 HEATR1 SRSF9 YTHDF2 TOP2A ESF1 | 2.37e-04 | 1353 | 79 | 11 | 29467282 |
| Pubmed | FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. | 2.60e-04 | 248 | 79 | 5 | 27926873 | |
| Pubmed | 2.88e-04 | 560 | 79 | 7 | 35241646 | ||
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 3.17e-04 | 259 | 79 | 5 | 30404004 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 3.34e-04 | 262 | 79 | 5 | 36880596 | |
| Pubmed | 3.35e-04 | 59 | 79 | 3 | 20855565 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 3.63e-04 | 582 | 79 | 7 | 20467437 | |
| Pubmed | 3.86e-04 | 777 | 79 | 8 | 35844135 | ||
| Pubmed | TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF. | 3.91e-04 | 13 | 79 | 2 | 16052631 | |
| Pubmed | NCAPG COPG1 BCLAF1 NPEPPS HEATR1 TUBGCP2 SRSF9 YTHDF2 TOP2A CDKAL1 NDUFS8 | 4.02e-04 | 1440 | 79 | 11 | 30833792 | |
| Pubmed | 4.25e-04 | 64 | 79 | 3 | 36369321 | ||
| Pubmed | 4.40e-04 | 601 | 79 | 7 | 33658012 | ||
| Pubmed | 4.55e-04 | 14 | 79 | 2 | 22055502 | ||
| Pubmed | Comprehensive Proteomic Analysis of PGC7-Interacting Proteins. | 5.06e-04 | 287 | 79 | 5 | 28712289 | |
| Pubmed | 5.19e-04 | 162 | 79 | 4 | 23012479 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 5.22e-04 | 1024 | 79 | 9 | 24711643 | |
| Pubmed | 5.25e-04 | 15 | 79 | 2 | 21045126 | ||
| Pubmed | 5.31e-04 | 69 | 79 | 3 | 35264565 | ||
| Pubmed | 5.99e-04 | 16 | 79 | 2 | 11279102 | ||
| Pubmed | 5.99e-04 | 16 | 79 | 2 | 28439006 | ||
| Pubmed | 5.99e-04 | 16 | 79 | 2 | 27328943 | ||
| Cytoband | 19q13.3 | 3.94e-04 | 82 | 79 | 3 | 19q13.3 | |
| Cytoband | 20p12.1 | 8.55e-04 | 25 | 79 | 2 | 20p12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.37e-03 | 473 | 79 | 5 | chr17q21 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-E|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.75e-07 | 174 | 79 | 6 | 4a1b67ce5ea353b3f81f59fa57da07668146afca | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-06 | 195 | 79 | 6 | 4658fb197657d7692ee344ae76b11b0210c418ba | |
| ToppCell | Control-B_naive-8|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.35e-06 | 196 | 79 | 6 | 54074da84000e4749ade8acc542f05a275bf829f | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.48e-06 | 199 | 79 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.48e-06 | 199 | 79 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.16e-05 | 166 | 79 | 5 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-05 | 167 | 79 | 5 | 3461d14e36f09ddc6ee5549ca4797e16d3f37fcc | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.81e-05 | 182 | 79 | 5 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | NS-control-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.81e-05 | 182 | 79 | 5 | f623c47e7806181d09f126066a952162ce49a306 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 184 | 79 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 184 | 79 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 184 | 79 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 1.91e-05 | 184 | 79 | 5 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.01e-05 | 186 | 79 | 5 | dae6a98963c78bf7518ebab8dc02f173c3b0f7f7 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.01e-05 | 186 | 79 | 5 | 080e56113b89138277a2bd2eabddfa6cd1a18b61 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 189 | 79 | 5 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 189 | 79 | 5 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | COPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 2.23e-05 | 190 | 79 | 5 | ed978cd5d9da87b49878a330e362762c487f849f | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.23e-05 | 190 | 79 | 5 | 2434b8ad2976eab7d9147012c28454ab29670709 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.23e-05 | 190 | 79 | 5 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-05 | 193 | 79 | 5 | 5c6b03d6d98aa873fda1a201d44a912246bb5a92 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-05 | 193 | 79 | 5 | d4b58eee97043b4337ec36c40f9af6499d864df9 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-05 | 194 | 79 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-early|World / Primary Cells by Cluster | 2.59e-05 | 196 | 79 | 5 | dd3c6ea5e4ebcc27064f16507de6db6dc8f86fa8 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-early-1|World / Primary Cells by Cluster | 2.59e-05 | 196 | 79 | 5 | 70fe6a1a6de891832aaa6276c985b326985e14db | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.65e-05 | 197 | 79 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | systemic_lupus_erythematosus-treated|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.72e-05 | 198 | 79 | 5 | 8165ff735095c52994fb5057d89be93cc378b7da | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.72e-05 | 198 | 79 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 2.72e-05 | 198 | 79 | 5 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 2.72e-05 | 198 | 79 | 5 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.72e-05 | 198 | 79 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 2.78e-05 | 199 | 79 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.78e-05 | 199 | 79 | 5 | 236b1417ed0875e98c6ec1ec714003bfce438d65 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-05 | 199 | 79 | 5 | 9735a1dc10910f02f1106b20ae5ab4c09c21305e | |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | 2.85e-05 | 200 | 79 | 5 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 | |
| ToppCell | TCGA-Skin|World / Sample_Type by Project: Shred V9 | 1.13e-04 | 140 | 79 | 4 | 57d9979bfdcb695869690bf62fa80759ad06eb6c | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-04 | 142 | 79 | 4 | be63c48794a227ea55978524c0f5935342fc455e | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 151 | 79 | 4 | c06a54afe918b14f885d6a85fbcf81e80f33afae | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.58e-04 | 153 | 79 | 4 | 61fe71e32fc9c8cad875bc087aad0b0ff680bf45 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-04 | 156 | 79 | 4 | 4877aabf647238c0279e497345b6a6d5ee07ef9c | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-04 | 156 | 79 | 4 | 1d681fa17e62815f5d5f90c86be3c248b38e011b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 2.02e-04 | 163 | 79 | 4 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-04 | 163 | 79 | 4 | 3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-04 | 164 | 79 | 4 | 249d8f75a64bce7db52ce0c563f496b9edf602a6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Cilia-bearing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.07e-04 | 164 | 79 | 4 | 346e1530b4bf30adbcb2f7d64fdfb4cd8df69d7f | |
| ToppCell | 10x5'-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Lung / Manually curated celltypes from each tissue | 2.21e-04 | 167 | 79 | 4 | 82739226347d74897be000f429b73543a031af96 | |
| ToppCell | 10x5'-Lung-Hematopoietic_progenitors|Lung / Manually curated celltypes from each tissue | 2.21e-04 | 167 | 79 | 4 | dec18caf0475002d4ad3c7bc7fc3050cbc8e6bae | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 168 | 79 | 4 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 168 | 79 | 4 | 96f7411474edd673b8d3ee6b8a8bb185c246daaf | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 168 | 79 | 4 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.32e-04 | 169 | 79 | 4 | 58136b8a0bf2dab45c91a053ef7225ea49ccb871 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 169 | 79 | 4 | 8dba7546adc6b1345933eec81fc77fc9611fae60 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.32e-04 | 169 | 79 | 4 | 04c6ed38e1d1befba5ef5f37a3c1e045a0b163d6 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.32e-04 | 169 | 79 | 4 | 4db49b7eaea34e6558ee73b01e76315e99cc880b | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 169 | 79 | 4 | d2862a7ddee6d7a65d84ef9d0800ba6f4690973f | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.42e-04 | 171 | 79 | 4 | e3cab55f39879e2bd3e8bda91802181075839bc4 | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 171 | 79 | 4 | ff117bf1a0755aa7d7c3db29749a7b9b90cc0b2f | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.42e-04 | 171 | 79 | 4 | 52fdc2a4ec36fb91583b1215362548ceb6740ae1 | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 172 | 79 | 4 | 95219814e37259e34be053572cc95d4639360c27 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 172 | 79 | 4 | 6004327045f03d832fdabe6cb2f8b1b1db57789a | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.48e-04 | 172 | 79 | 4 | c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 172 | 79 | 4 | 31c5710fd7ebb221e703545595f5ec0ee3a32bcf | |
| ToppCell | droplet-Spleen-SPLEEN|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 172 | 79 | 4 | d32731a56e113ff0ef7167b23959d69baf2068f9 | |
| ToppCell | droplet-Spleen-SPLEEN-30m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 172 | 79 | 4 | 02cc4a9fb7902c572cee37ba828749db4913ee87 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-04 | 173 | 79 | 4 | 31784679190fbd95fc23d7c66008eb21b8c7cc5d | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-04 | 173 | 79 | 4 | 20a20429aa898097d5ec4880ed64846558b5890f | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.59e-04 | 174 | 79 | 4 | 94575a605c725de83f66a6cf7df9d7bb360ffc56 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.59e-04 | 174 | 79 | 4 | 40c81ab36d7931e271e20d7d56fed32463c75f41 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-04 | 174 | 79 | 4 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-04 | 174 | 79 | 4 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.59e-04 | 174 | 79 | 4 | b43fb0fbb492c1be6e791a1c4d6c4e5956955ee4 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.65e-04 | 175 | 79 | 4 | a6913f992a1ea20b43e5adeca3ede3a6fda820ad | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.65e-04 | 175 | 79 | 4 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.70e-04 | 176 | 79 | 4 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-04 | 177 | 79 | 4 | 3e149bff1f1b393a7abe98984e37981c8296f95d | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-04 | 177 | 79 | 4 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-04 | 177 | 79 | 4 | 73ba0f0b4b33f10e9f036d6d9befa48a1258e682 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-04 | 178 | 79 | 4 | a493a277d175e5e153410a745b26ebe2e0839ea0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-04 | 178 | 79 | 4 | 371218babddfd3d8a7bb82a46ce65327ee3fcf12 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-04 | 178 | 79 | 4 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.88e-04 | 179 | 79 | 4 | ec69e1dd897414033ba5b007aa82655a79adca6c | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.88e-04 | 179 | 79 | 4 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-04 | 179 | 79 | 4 | 804aa3899585fc7e662eff9f6d41f48655f16dd6 | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasmablasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.88e-04 | 179 | 79 | 4 | 58c8996120637315dcbd1991a71516c09173051e | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_Erythro-Mega|lymph-node_spleen / Manually curated celltypes from each tissue | 2.88e-04 | 179 | 79 | 4 | 957c08ad4b46eb4cc1717c45056fc3db50015fdc | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_T-T_NK-CD8_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.95e-04 | 180 | 79 | 4 | 5273aa2b939b5c640d708d6ca1812550dff5ec0f | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-04 | 180 | 79 | 4 | 178648429686e6d4e6f3aafc350130e819788ecf | |
| ToppCell | control-Lymphoid-NKT-proliferating|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.95e-04 | 180 | 79 | 4 | 535535a67b3f3320bad2f98b1bc98a7b0ee77840 | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-04 | 180 | 79 | 4 | fcd5d5bf00ee728162b0aac4c81eb78e742cf6f2 | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-04 | 180 | 79 | 4 | c2a8f61c806f6f6f47743e9f7c9700705db43386 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-04 | 181 | 79 | 4 | e0c46e2d52c97893e5894a51d2699e8a8a11eefc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.01e-04 | 181 | 79 | 4 | c35ca98c474e31917e0a53c092397e0d8d18b37c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.01e-04 | 181 | 79 | 4 | 73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 181 | 79 | 4 | 3fe648db1cb8326066d8bde3ca1287c5c9af19bd | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 181 | 79 | 4 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 181 | 79 | 4 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating-Lymphatic_EC_proliferating_L.2.5.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.07e-04 | 182 | 79 | 4 | f703963b5d1e8c1f95d78807521048553b0792d8 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 182 | 79 | 4 | a512863304fad80acaab60a8c6107eb7c9cbac99 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.07e-04 | 182 | 79 | 4 | ebd177ad5eac51bf2db0657596618bdf1e5d46e1 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.14e-04 | 183 | 79 | 4 | 52af3c943116073c8ddd207b664342960b88929b | |
| Disease | short bowel syndrome (biomarker_via_orthology) | 6.04e-06 | 2 | 73 | 2 | DOID:10605 (biomarker_via_orthology) | |
| Disease | gestational diabetes (is_implicated_in) | 1.67e-04 | 8 | 73 | 2 | DOID:11714 (is_implicated_in) | |
| Disease | chronic kidney disease (implicated_via_orthology) | 3.92e-04 | 12 | 73 | 2 | DOID:784 (implicated_via_orthology) | |
| Disease | Diabetic Asymmetric Polyneuropathy | 5.39e-04 | 14 | 73 | 2 | C0393835 | |
| Disease | Diabetic Neuralgia | 5.39e-04 | 14 | 73 | 2 | C0751074 | |
| Disease | Diabetic Neuropathies | 5.39e-04 | 14 | 73 | 2 | C0011882 | |
| Disease | Asymmetric Diabetic Proximal Motor Neuropathy | 5.39e-04 | 14 | 73 | 2 | C0271674 | |
| Disease | Symmetric Diabetic Proximal Motor Neuropathy | 5.39e-04 | 14 | 73 | 2 | C0271673 | |
| Disease | Diabetic Mononeuropathy | 5.39e-04 | 14 | 73 | 2 | C0271678 | |
| Disease | Diabetic Autonomic Neuropathy | 5.39e-04 | 14 | 73 | 2 | C0271686 | |
| Disease | Diabetic Amyotrophy | 5.39e-04 | 14 | 73 | 2 | C0271685 | |
| Disease | Diabetic Polyneuropathies | 5.39e-04 | 14 | 73 | 2 | C0271680 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 8.68e-04 | 171 | 73 | 4 | DOID:9352 (is_implicated_in) | |
| Disease | serum amyloid A-1 protein measurement | 9.00e-04 | 18 | 73 | 2 | EFO_0008282 | |
| Disease | disease of metabolism (implicated_via_orthology) | 1.23e-03 | 21 | 73 | 2 | DOID:0014667 (implicated_via_orthology) | |
| Disease | Impaired glucose tolerance | 1.75e-03 | 25 | 73 | 2 | C0271650 | |
| Disease | Acute kidney injury | 1.75e-03 | 25 | 73 | 2 | HP_0001919 | |
| Disease | Endogenous Hyperinsulinism | 1.89e-03 | 26 | 73 | 2 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 1.89e-03 | 26 | 73 | 2 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 1.89e-03 | 26 | 73 | 2 | C1257965 | |
| Disease | Hyperinsulinism | 2.19e-03 | 28 | 73 | 2 | C0020459 | |
| Disease | Diabetes Mellitus, Non-Insulin-Dependent | 2.23e-03 | 221 | 73 | 4 | C0011860 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 2.27e-03 | 105 | 73 | 3 | DOID:9352 (implicated_via_orthology) | |
| Disease | diabetes mellitus (is_implicated_in) | 2.35e-03 | 29 | 73 | 2 | DOID:9351 (is_implicated_in) | |
| Disease | urinary bladder cancer (is_marker_for) | 2.40e-03 | 107 | 73 | 3 | DOID:11054 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YRSSVFADVETHFRT | 401 | P59817 | |
| REVATDHKAFYVLFT | 716 | Q92888 | |
| VRVIFTDTFSYHLKF | 126 | Q8IUA7 | |
| ASEREDLVYFEHKSF | 1826 | Q9UIF8 | |
| YKISADTHQFSVTER | 261 | Q96RQ1 | |
| LVEVFESEHSRRKYF | 956 | Q9HAR2 | |
| RPYFTIHDSEFKEFT | 306 | Q8NEG7 | |
| EKTTYEETHICSEFF | 1206 | Q96F81 | |
| TLNTDFVSKHFTVEY | 101 | Q9UKP5 | |
| HYEIFTEQFSFKEVR | 151 | Q14894 | |
| VYSVTDKASFEHVDR | 91 | O14807 | |
| YADSIHAIFVETSAK | 136 | Q9UL26 | |
| SERYVHTFKDLSNFS | 66 | Q9UBM8 | |
| RFVEKEDLLSHFYET | 306 | Q92604 | |
| LSFYTTEEKIHELFS | 46 | A6PVI3 | |
| SSKDHQLDTRVSEFY | 131 | O95671 | |
| HSQTLSEDERFKEFT | 471 | Q9UPZ3 | |
| ESHIYRVSFTDFKET | 311 | Q8N1V2 | |
| SHSTTEDLKRFYDLS | 61 | Q9H501 | |
| CTFVYKEFSRFHEEI | 781 | P16499 | |
| YDVVSDHVSKVTFFN | 381 | P48357 | |
| TESHTVFIDYQEKER | 981 | Q8NG31 | |
| EVFIRSSFKDVDHLF | 366 | P32455 | |
| SAVTRFIEEKSSFEY | 271 | Q9BSJ2 | |
| SSFRKTFEDYLHNVV | 726 | P06213 | |
| EERVFSAYHSSLAFT | 261 | P46093 | |
| ELSYTFSHASEDIRK | 276 | Q9Y5F1 | |
| YVSSDDEFIVKTVRH | 131 | A2A3N6 | |
| VFTDARSKDYRLTHE | 141 | Q96RW7 | |
| FEFSTETHEELLYNK | 171 | O00217 | |
| FSSDFVKHLSEFRVI | 3586 | Q9P2D7 | |
| YFAEVDRVDSHFTSI | 331 | Q96RP8 | |
| HYISTFKTRQDIIDF | 971 | Q9H7D0 | |
| DIIHTKETLTFVFEY | 166 | Q96Q40 | |
| LVTEESFDSKFYVAH | 441 | Q5VV42 | |
| YLETHFRDVSSTEEF | 156 | Q9H2C0 | |
| RFTSYQKATEEHSTR | 631 | Q9NYF8 | |
| IHDSEFKEYTTRTQA | 331 | Q8IWF6 | |
| TAKILESERFDTHEY | 276 | Q9UHN6 | |
| YIFSAEFITADSSKE | 251 | O43148 | |
| FEIFKEHFSSEVTIS | 541 | Q9H583 | |
| KSLEVSDTRFHSFSF | 156 | Q9NWZ3 | |
| ESETEYVIRCTKHTF | 641 | Q9Y678 | |
| HNRFTKETYDFDIAV | 311 | P00742 | |
| HSRFIVSLAYAFETK | 246 | Q15835 | |
| KEFTSYFQRHDEVLT | 631 | O94887 | |
| ISTEFSAELHYKVDV | 406 | B1AKI9 | |
| LSHTDFYEEIQEFVK | 666 | P55786 | |
| TISYAFFHASEEIRK | 276 | Q9Y5E6 | |
| FDFEKVRYSSTETLA | 571 | Q8NAN2 | |
| FRKAVTDFTSEVTYD | 251 | Q9UGM6 | |
| VSHKTENTYRFLTFA | 6 | O75691 | |
| DRSHIYTFTDTFTEK | 476 | Q9HCM9 | |
| DDTKFRSHEGETSYI | 166 | Q13242 | |
| DAVYERTSDHKIVFF | 386 | Q9ULZ9 | |
| KDFSETYERFHTESL | 191 | Q96MH2 | |
| HETECITFLKDFTYS | 321 | P55055 | |
| SFAKSHRFDVEFVDE | 1306 | Q149N8 | |
| REDYKFHHTFSTEIA | 331 | P13667 | |
| ETKDVSEYSCRELHF | 71 | Q9BQB4 | |
| VFSDTETEKHSYRSV | 691 | Q9Y4F9 | |
| ERVIEFAAKFVTSFH | 66 | Q9BPX3 | |
| TTSIFDDFAHYEKRQ | 556 | Q7Z739 | |
| FAREIEEHVFTLYSK | 201 | Q8N8B7 | |
| REDERKFTSTCHFTY | 96 | Q96LM6 | |
| FEATYRKETTSFHLE | 81 | A0A087WT02 | |
| VHFRISDDKIFTDIF | 51 | Q8IZH2 | |
| VKLSDFDREHFSEVF | 341 | Q8IZH2 | |
| ETLKEFSTIYKHFDE | 2271 | P02549 | |
| TYCTKEFVFDTIQSH | 196 | Q9BUZ4 | |
| VYDFVSHSRKEETVT | 111 | Q9BZX2 | |
| DYREYHTDTTVKFVV | 956 | P11388 | |
| ITTVRSFLDDFESKY | 386 | Q8TF74 | |
| VRYFVDHNTRTTTFK | 511 | Q9H0M0 | |
| STRFAATFYDIETLK | 86 | O43915 | |
| KEYVETFSHSTALFV | 216 | Q9BR84 | |
| ETDISIQRFHKYDAF | 176 | Q96RE9 | |
| TSIFDDFSHYEKRQE | 551 | Q9Y5A9 | |
| EYTECDTFRSTFHSK | 196 | Q9NR11 | |
| EKLHTLEEFSYEFFR | 1606 | Q6PIF6 | |
| QLKETFERHSRVYTF | 111 | Q00872 |